Status:
COMPLETED
Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy
Lead Sponsor:
Daiichi Sankyo Co., Ltd.
Conditions:
Pain
Diabetic Peripheral Neuropathy
Eligibility:
All Genders
20+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to investigate the effectiveness and safety of DS-5565, compared to placebo, in subjects with pain associated with diabetic peripheral neuropathy.
Eligibility Criteria
Inclusion
- Type 1 or Type 2 diabetes mellitus
- Painful distal symmetric polyneuropathy
- Average daily pain score is great than or equal to 4
Exclusion
- HbA1c greater than 9.0
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT01504412
Start Date
January 1 2012
End Date
June 1 2013
Last Update
March 18 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Tokyo, Japan
2
Seoul, South Korea
3
Taipei, Taiwan